Reference
Kries K, et al. Treatment-Related Healthcare Costs of Metastatic Castration-Resistant Prostate Cancer in Germany: A Claims Data Study. PharmacoEconomics-Open : 30 May 2020. Available from: URL: https://doi.org/10.1007/s41669-020-00219-6
Rights and permissions
About this article
Cite this article
Healthcare costs differ for metastatic castration-resistant prostate cancer. PharmacoEcon Outcomes News 855, 16 (2020). https://doi.org/10.1007/s40274-020-6881-7
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-020-6881-7